Reinilde Heyrman
2015
In 2015, Reinilde Heyrman earned a total compensation of $548.4K as former Chief Clinical Development Officer at Bellerophon Therapeutics, a 25% decrease compared to previous year.
Compensation breakdown
| Option Awards | $17,097 |
|---|---|
| Salary | $333,462 |
| Other | $197,796 |
| Total | $548,356 |
Heyrman received $333.5K in salary, accounting for 61% of the total pay in 2015.
Heyrman also received $17.1K in option awards and $197.8K in other compensation.
Rankings
In 2015, Reinilde Heyrman's compensation ranked 10,472nd out of 13,638 executives tracked by ExecPay. In other words, Heyrman earned more than 23.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,472 out of 13,638 | 23rd |
Division Manufacturing | 3,995 out of 5,190 | 23rd |
Major group Chemicals And Allied Products | 1,472 out of 1,854 | 21st |
Industry group Drugs | 1,212 out of 1,528 | 21st |
Industry Pharmaceutical Preparations | 948 out of 1,182 | 20th |
Source: SEC filing on April 27, 2016.
Heyrman's colleagues
We found five more compensation records of executives who worked with Reinilde Heyrman at Bellerophon Therapeutics in 2015.
2015
Jonathan Peacock
Bellerophon Therapeutics
Chief Executive Officer
2015
Martin Meglasson
Bellerophon Therapeutics
Chief Scientific Officer
2015
Deborah Quinn
Bellerophon Therapeutics
Chief Medical Officer
2015
Martin Dekker
Bellerophon Therapeutics
Vice President of Device Engineering and Manufacturing
2015
Peter Fernandes
Bellerophon Therapeutics